Listed

Aquestive Therapeutics, Inc.

AQSTNasdaqCIK 1398733HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$13.8m, Q2 FY2026
Operating income−$8.2m, Q2 FY2026
Net income−$22.9m, Q2 FY2026
Aquestive Therapeutics, Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m13.0Revenue, Q3 FY2023, three months to 2023-09-30$13.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-04, accession 0001628280-24-045030.Report this figure13.2Revenue, Q4 FY2023, three months to 2023-12-31$13.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-05, accession 0001628280-25-010506. Derived: 12-month figure less the 9-month figure.Report this figure12.1Revenue, Q1 FY2024, three months to 2024-03-31$12.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-12, accession 0001628280-25-024664.Report this figure20.1Revenue, Q2 FY2024, three months to 2024-06-30$20.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-11, accession 0001398733-25-000013.Report this figure13.5Revenue, Q3 FY2024, three months to 2024-09-30$13.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-05, accession 0001398733-25-000028.Report this figure11.9Revenue, Q4 FY2024, three months to 2024-12-31$11.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-04, accession 0001398733-26-000018. Derived: 12-month figure less the 9-month figure.Report this figure8.7Revenue, Q1 FY2025, three months to 2025-03-31$8.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-13, accession 0001398733-26-000030.Report this figure10.0Revenue, Q2 FY2025, three months to 2025-06-30$10.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-11, accession 0001398733-26-000042.Report this figure12.8Revenue, Q3 FY2025, three months to 2025-09-30$12.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-05, accession 0001398733-25-000028.Report this figure13.0Revenue, Q4 FY2025, three months to 2025-12-31$13.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-04, accession 0001398733-26-000018. Derived: 12-month figure less the 9-month figure.Report this figure14.4Revenue, Q1 FY2026, three months to 2026-03-31$14.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-13, accession 0001398733-26-000030.Report this figure13.8Revenue, Q2 FY2026, three months to 2026-06-30$13.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-11, accession 0001398733-26-000042.Report this figure
Cost of revenue$m4.8Cost of revenue, Q3 FY2023, three months to 2023-09-30$4.8m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2024-11-04, accession 0001628280-24-045030.Report this figure4.7Cost of revenue, Q4 FY2023, three months to 2023-12-31$4.7m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2025-03-05, accession 0001628280-25-010506. Derived: 12-month figure less the 9-month figure.Report this figure4.4Cost of revenue, Q1 FY2024, three months to 2024-03-31$4.4m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-05-12, accession 0001628280-25-024664.Report this figure4.5Cost of revenue, Q2 FY2024, three months to 2024-06-30$4.5m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-08-11, accession 0001398733-25-000013.Report this figure4.4Cost of revenue, Q3 FY2024, three months to 2024-09-30$4.4m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-05, accession 0001398733-25-000028.Report this figure4.5Cost of revenue, Q4 FY2024, three months to 2024-12-31$4.5m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-03-04, accession 0001398733-26-000018. Derived: 12-month figure less the 9-month figure.Report this figure3.7Cost of revenue, Q1 FY2025, three months to 2025-03-31$3.7m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-13, accession 0001398733-26-000030.Report this figure4.6Cost of revenue, Q2 FY2025, three months to 2025-06-30$4.6m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-11, accession 0001398733-26-000042.Report this figure4.5Cost of revenue, Q3 FY2025, three months to 2025-09-30$4.5m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-05, accession 0001398733-25-000028.Report this figure5.8Cost of revenue, Q4 FY2025, three months to 2025-12-31$5.8m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-03-04, accession 0001398733-26-000018. Derived: 12-month figure less the 9-month figure.Report this figure3.5Cost of revenue, Q1 FY2026, three months to 2026-03-31$3.5m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-13, accession 0001398733-26-000030.Report this figure4.0Cost of revenue, Q2 FY2026, three months to 2026-06-30$4.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-11, accession 0001398733-26-000042.Report this figure
Research and development$m3.2Research and development, Q3 FY2023, three months to 2023-09-30$3.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-04, accession 0001628280-24-045030.Report this figure2.9Research and development, Q4 FY2023, three months to 2023-12-31$2.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-05, accession 0001628280-25-010506. Derived: 12-month figure less the 9-month figure.Report this figure5.9Research and development, Q1 FY2024, three months to 2024-03-31$5.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-12, accession 0001628280-25-024664.Report this figure4.2Research and development, Q2 FY2024, three months to 2024-06-30$4.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-11, accession 0001398733-25-000013.Report this figure5.3Research and development, Q3 FY2024, three months to 2024-09-30$5.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-05, accession 0001398733-25-000028.Report this figure4.9Research and development, Q4 FY2024, three months to 2024-12-31$4.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-04, accession 0001398733-26-000018. Derived: 12-month figure less the 9-month figure.Report this figure5.4Research and development, Q1 FY2025, three months to 2025-03-31$5.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-13, accession 0001398733-26-000030.Report this figure4.1Research and development, Q2 FY2025, three months to 2025-06-30$4.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-11, accession 0001398733-26-000042.Report this figure4.5Research and development, Q3 FY2025, three months to 2025-09-30$4.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-05, accession 0001398733-25-000028.Report this figure3.2Research and development, Q4 FY2025, three months to 2025-12-31$3.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-04, accession 0001398733-26-000018. Derived: 12-month figure less the 9-month figure.Report this figure4.2Research and development, Q1 FY2026, three months to 2026-03-31$4.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-13, accession 0001398733-26-000030.Report this figure4.0Research and development, Q2 FY2026, three months to 2026-06-30$4.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-11, accession 0001398733-26-000042.Report this figure
Selling, general and administrative$m7.4Selling, general and administrative, Q3 FY2023, three months to 2023-09-30$7.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2024-11-04, accession 0001628280-24-045030.Report this figure9.6Selling, general and administrative, Q4 FY2023, three months to 2023-12-31$9.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2025-03-05, accession 0001628280-25-010506. Derived: 12-month figure less the 9-month figure.Report this figure10.7Selling, general and administrative, Q1 FY2024, three months to 2024-03-31$10.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-05-12, accession 0001628280-25-024664.Report this figure11.4Selling, general and administrative, Q2 FY2024, three months to 2024-06-30$11.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-08-11, accession 0001398733-25-000013.Report this figure12.1Selling, general and administrative, Q3 FY2024, three months to 2024-09-30$12.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-05, accession 0001398733-25-000028.Report this figure16.0Selling, general and administrative, Q4 FY2024, three months to 2024-12-31$16.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-03-04, accession 0001398733-26-000018. Derived: 12-month figure less the 9-month figure.Report this figure19.1Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$19.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-13, accession 0001398733-26-000030.Report this figure12.7Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$12.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-11, accession 0001398733-26-000042.Report this figure15.3Selling, general and administrative, Q3 FY2025, three months to 2025-09-30$15.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-05, accession 0001398733-25-000028.Report this figure32.8Selling, general and administrative, Q4 FY2025, three months to 2025-12-31$32.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-03-04, accession 0001398733-26-000018. Derived: 12-month figure less the 9-month figure.Report this figure11.0Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$11.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-13, accession 0001398733-26-000030.Report this figure14.1Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$14.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-11, accession 0001398733-26-000042.Report this figure
Operating income$m(2.4)Operating income, Q3 FY2023, three months to 2023-09-30−$2.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-04, accession 0001628280-24-045030.Report this figure(3.9)Operating income, Q4 FY2023, three months to 2023-12-31−$3.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-05, accession 0001628280-25-010506. Derived: 12-month figure less the 9-month figure.Report this figure(9.0)Operating income, Q1 FY2024, three months to 2024-03-31−$9.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-12, accession 0001628280-25-024664.Report this figure0.1Operating income, Q2 FY2024, three months to 2024-06-30$55.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-11, accession 0001398733-25-000013.Report this figure(8.3)Operating income, Q3 FY2024, three months to 2024-09-30−$8.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-05, accession 0001398733-25-000028.Report this figure(13.6)Operating income, Q4 FY2024, three months to 2024-12-31−$13.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-04, accession 0001398733-26-000018. Derived: 12-month figure less the 9-month figure.Report this figure(19.4)Operating income, Q1 FY2025, three months to 2025-03-31−$19.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-13, accession 0001398733-26-000030.Report this figure(11.4)Operating income, Q2 FY2025, three months to 2025-06-30−$11.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-11, accession 0001398733-26-000042.Report this figure(11.5)Operating income, Q3 FY2025, three months to 2025-09-30−$11.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-05, accession 0001398733-25-000028.Report this figure(28.8)Operating income, Q4 FY2025, three months to 2025-12-31−$28.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-04, accession 0001398733-26-000018. Derived: 12-month figure less the 9-month figure.Report this figure(4.2)Operating income, Q1 FY2026, three months to 2026-03-31−$4.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-13, accession 0001398733-26-000030.Report this figure(8.2)Operating income, Q2 FY2026, three months to 2026-06-30−$8.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-11, accession 0001398733-26-000042.Report this figure
Interest expense$m1.3Interest expense, Q3 FY2023, three months to 2023-09-30$1.3m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2023-11-06, accession 0001628280-23-037100.Report this figure2.3Interest expense, Q4 FY2023, three months to 2023-12-31$2.3m. XBRL concept us-gaap:InterestExpense. 10-K filed 2024-03-05, accession 0001628280-24-009010. Derived: 12-month figure less the 9-month figure.Report this figure2.8Interest expense, Q1 FY2024, three months to 2024-03-31$2.8m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-05-07, accession 0001628280-24-021118.Report this figure2.8Interest expense, Q2 FY2024, three months to 2024-06-30$2.8m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-08-06, accession 0001628280-24-035225.Report this figure2.8Interest expense, Q3 FY2024, three months to 2024-09-30$2.8m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-05, accession 0001398733-25-000028.Report this figure2.8Interest expense, Q4 FY2024, three months to 2024-12-31$2.8m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-03-04, accession 0001398733-26-000018. Derived: 12-month figure less the 9-month figure.Report this figure2.8Interest expense, Q1 FY2025, three months to 2025-03-31$2.8m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-13, accession 0001398733-26-000030.Report this figure2.8Interest expense, Q2 FY2025, three months to 2025-06-30$2.8m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-11, accession 0001398733-26-000042.Report this figure2.8Interest expense, Q3 FY2025, three months to 2025-09-30$2.8m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-05, accession 0001398733-25-000028.Report this figure2.8Interest expense, Q4 FY2025, three months to 2025-12-31$2.8m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-03-04, accession 0001398733-26-000018. Derived: 12-month figure less the 9-month figure.Report this figure2.9Interest expense, Q1 FY2026, three months to 2026-03-31$2.9m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-13, accession 0001398733-26-000030.Report this figure2.8Interest expense, Q2 FY2026, three months to 2026-06-30$2.8m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-11, accession 0001398733-26-000042.Report this figure
Income tax$m(0.1)Income tax, Q3 FY2023, three months to 2023-09-30−$140.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-04, accession 0001628280-24-045030.Report this figure0.1Income tax, Q4 FY2023, three months to 2023-12-31$101.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2025-03-05, accession 0001628280-25-010506. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-12, accession 0001628280-25-024664.Report this figure0.0Income tax, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-11, accession 0001398733-25-000013.Report this figure0.0Income tax, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-05, accession 0001398733-25-000028.Report this figure(0.0)Income tax, Q4 FY2024, three months to 2024-12-31−$14.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-04, accession 0001398733-26-000018. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-13, accession 0001398733-26-000030.Report this figure0.0Income tax, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-11, accession 0001398733-26-000042.Report this figure0.0Income tax, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-05, accession 0001398733-25-000028.Report this figure0.0Income tax, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-04, accession 0001398733-26-000018. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-13, accession 0001398733-26-000030.Report this figure0.0Income tax, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-11, accession 0001398733-26-000042.Report this figure
Net income$m(2.0)Net income, Q3 FY2023, three months to 2023-09-30−$2.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-04, accession 0001628280-24-045030.Report this figure(8.1)Net income, Q4 FY2023, three months to 2023-12-31−$8.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-05, accession 0001628280-25-010506. Derived: 12-month figure less the 9-month figure.Report this figure(12.8)Net income, Q1 FY2024, three months to 2024-03-31−$12.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0001398733-25-000028.Report this figure(2.7)Net income, Q2 FY2024, three months to 2024-06-30−$2.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0001398733-25-000028.Report this figure(11.5)Net income, Q3 FY2024, three months to 2024-09-30−$11.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0001398733-25-000028.Report this figure(17.1)Net income, Q4 FY2024, three months to 2024-12-31−$17.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-04, accession 0001398733-26-000018. Derived: 12-month figure less the 9-month figure.Report this figure(22.9)Net income, Q1 FY2025, three months to 2025-03-31−$22.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001398733-26-000042.Report this figure(13.5)Net income, Q2 FY2025, three months to 2025-06-30−$13.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001398733-26-000042.Report this figure(15.4)Net income, Q3 FY2025, three months to 2025-09-30−$15.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0001398733-25-000028.Report this figure(31.9)Net income, Q4 FY2025, three months to 2025-12-31−$31.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-04, accession 0001398733-26-000018. Derived: 12-month figure less the 9-month figure.Report this figure(8.1)Net income, Q1 FY2026, three months to 2026-03-31−$8.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001398733-26-000042.Report this figure(22.9)Net income, Q2 FY2026, three months to 2026-06-30−$22.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001398733-26-000042.Report this figure
Diluted EPS$ per share(0.03)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.03 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-04, accession 0001628280-24-045030.Report this figurenot reported(0.17)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.17 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-12, accession 0001628280-25-024664.Report this figure(0.03)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.03 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-11, accession 0001398733-25-000013.Report this figure(0.13)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.13 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-05, accession 0001398733-25-000028.Report this figurenot reported(0.24)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.24 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-13, accession 0001398733-26-000030.Report this figure(0.14)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.14 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-11, accession 0001398733-26-000042.Report this figure(0.14)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.14 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-05, accession 0001398733-25-000028.Report this figurenot reported(0.07)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.07 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-13, accession 0001398733-26-000030.Report this figure(0.18)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.18 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-11, accession 0001398733-26-000042.Report this figure
Basic EPS$ per share(0.03)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.03 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-04, accession 0001628280-24-045030.Report this figurenot reported(0.17)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.17 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-12, accession 0001628280-25-024664.Report this figure(0.03)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.03 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-11, accession 0001398733-25-000013.Report this figure(0.13)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.13 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-05, accession 0001398733-25-000028.Report this figurenot reported(0.24)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.24 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-13, accession 0001398733-26-000030.Report this figure(0.14)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.14 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-11, accession 0001398733-26-000042.Report this figure(0.14)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.14 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-05, accession 0001398733-25-000028.Report this figurenot reported(0.07)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.07 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-13, accession 0001398733-26-000030.Report this figure(0.18)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.18 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-11, accession 0001398733-26-000042.Report this figure

Balance sheet

Cash and equivalents$98.5m, Q2 FY2026
Long-term debt$55.0m, Q2 FY2026
Shareholders' equity−$56.6m, Q2 FY2026
Aquestive Therapeutics, Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m24.9Cash and equivalents, Q3 FY2023, at 2023-09-30$24.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-06, accession 0001628280-23-037100.Report this figure23.9Cash and equivalents, FY2023, at 2023-12-31$23.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-04, accession 0001628280-24-045030.Report this figure95.2Cash and equivalents, Q1 FY2024, at 2024-03-31$95.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-07, accession 0001628280-24-021118.Report this figure89.9Cash and equivalents, Q2 FY2024, at 2024-06-30$89.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-06, accession 0001628280-24-035225.Report this figure77.9Cash and equivalents, Q3 FY2024, at 2024-09-30$77.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-04, accession 0001628280-24-045030.Report this figure71.5Cash and equivalents, FY2024, at 2024-12-31$71.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-05, accession 0001398733-25-000028.Report this figure68.7Cash and equivalents, Q1 FY2025, at 2025-03-31$68.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-12, accession 0001628280-25-024664.Report this figure60.5Cash and equivalents, Q2 FY2025, at 2025-06-30$60.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-11, accession 0001398733-25-000013.Report this figure129Cash and equivalents, Q3 FY2025, at 2025-09-30$129.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-05, accession 0001398733-25-000028.Report this figure121Cash and equivalents, FY2025, at 2025-12-31$121.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-11, accession 0001398733-26-000042.Report this figure111Cash and equivalents, Q1 FY2026, at 2026-03-31$110.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-13, accession 0001398733-26-000030.Report this figure98.5Cash and equivalents, Q2 FY2026, at 2026-06-30$98.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-11, accession 0001398733-26-000042.Report this figure
Current assets$m42.5Current assets, Q3 FY2023, at 2023-09-30$42.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-06, accession 0001628280-23-037100.Report this figure41.0Current assets, FY2023, at 2023-12-31$41.0m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-05, accession 0001628280-25-010506.Report this figure113Current assets, Q1 FY2024, at 2024-03-31$113.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-07, accession 0001628280-24-021118.Report this figure104Current assets, Q2 FY2024, at 2024-06-30$104.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-06, accession 0001628280-24-035225.Report this figure96.6Current assets, Q3 FY2024, at 2024-09-30$96.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-04, accession 0001628280-24-045030.Report this figure88.2Current assets, FY2024, at 2024-12-31$88.2m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-04, accession 0001398733-26-000018.Report this figure89.2Current assets, Q1 FY2025, at 2025-03-31$89.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-12, accession 0001628280-25-024664.Report this figure81.7Current assets, Q2 FY2025, at 2025-06-30$81.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-11, accession 0001398733-25-000013.Report this figure152Current assets, Q3 FY2025, at 2025-09-30$151.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-05, accession 0001398733-25-000028.Report this figure149Current assets, FY2025, at 2025-12-31$149.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-11, accession 0001398733-26-000042.Report this figure130Current assets, Q1 FY2026, at 2026-03-31$130.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-13, accession 0001398733-26-000030.Report this figure118Current assets, Q2 FY2026, at 2026-06-30$118.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-11, accession 0001398733-26-000042.Report this figure
Total assets$m59.4Total assets, Q3 FY2023, at 2023-09-30$59.4m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-06, accession 0001628280-23-037100.Report this figure57.4Total assets, FY2023, at 2023-12-31$57.4m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-05, accession 0001628280-25-010506.Report this figure130Total assets, Q1 FY2024, at 2024-03-31$129.5m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-07, accession 0001628280-24-021118.Report this figure118Total assets, Q2 FY2024, at 2024-06-30$117.6m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-06, accession 0001628280-24-035225.Report this figure110Total assets, Q3 FY2024, at 2024-09-30$110.0m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-04, accession 0001628280-24-045030.Report this figure101Total assets, FY2024, at 2024-12-31$101.4m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-04, accession 0001398733-26-000018.Report this figure102Total assets, Q1 FY2025, at 2025-03-31$102.2m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-12, accession 0001628280-25-024664.Report this figure93.7Total assets, Q2 FY2025, at 2025-06-30$93.7m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-11, accession 0001398733-25-000013.Report this figure164Total assets, Q3 FY2025, at 2025-09-30$163.6m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-05, accession 0001398733-25-000028.Report this figure160Total assets, FY2025, at 2025-12-31$160.4m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-11, accession 0001398733-26-000042.Report this figure141Total assets, Q1 FY2026, at 2026-03-31$141.1m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-13, accession 0001398733-26-000030.Report this figure132Total assets, Q2 FY2026, at 2026-06-30$132.1m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-11, accession 0001398733-26-000042.Report this figure
Current liabilities$m24.1Current liabilities, Q3 FY2023, at 2023-09-30$24.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-06, accession 0001628280-23-037100.Report this figure18.3Current liabilities, FY2023, at 2023-12-31$18.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-05, accession 0001628280-25-010506.Report this figure18.1Current liabilities, Q1 FY2024, at 2024-03-31$18.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-07, accession 0001628280-24-021118.Report this figure13.9Current liabilities, Q2 FY2024, at 2024-06-30$13.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-06, accession 0001628280-24-035225.Report this figure15.2Current liabilities, Q3 FY2024, at 2024-09-30$15.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-04, accession 0001628280-24-045030.Report this figure18.9Current liabilities, FY2024, at 2024-12-31$18.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-04, accession 0001398733-26-000018.Report this figure18.3Current liabilities, Q1 FY2025, at 2025-03-31$18.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-12, accession 0001628280-25-024664.Report this figure23.2Current liabilities, Q2 FY2025, at 2025-06-30$23.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-11, accession 0001398733-25-000013.Report this figure25.6Current liabilities, Q3 FY2025, at 2025-09-30$25.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-05, accession 0001398733-25-000028.Report this figure47.6Current liabilities, FY2025, at 2025-12-31$47.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-11, accession 0001398733-26-000042.Report this figure31.8Current liabilities, Q1 FY2026, at 2026-03-31$31.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-13, accession 0001398733-26-000030.Report this figure16.5Current liabilities, Q2 FY2026, at 2026-06-30$16.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-11, accession 0001398733-26-000042.Report this figure
Total liabilities$m162Total liabilities, Q3 FY2023, at 2023-09-30$162.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-06, accession 0001628280-23-037100.Report this figure164Total liabilities, FY2023, at 2023-12-31$163.9m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-05, accession 0001628280-25-010506.Report this figure166Total liabilities, Q1 FY2024, at 2024-03-31$165.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-07, accession 0001628280-24-021118.Report this figure153Total liabilities, Q2 FY2024, at 2024-06-30$153.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-06, accession 0001628280-24-035225.Report this figure155Total liabilities, Q3 FY2024, at 2024-09-30$155.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-04, accession 0001628280-24-045030.Report this figure162Total liabilities, FY2024, at 2024-12-31$161.6m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-04, accession 0001398733-26-000018.Report this figure163Total liabilities, Q1 FY2025, at 2025-03-31$163.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-12, accession 0001628280-25-024664.Report this figure166Total liabilities, Q2 FY2025, at 2025-06-30$166.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-11, accession 0001398733-25-000013.Report this figure168Total liabilities, Q3 FY2025, at 2025-09-30$167.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-05, accession 0001398733-25-000028.Report this figure194Total liabilities, FY2025, at 2025-12-31$194.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-11, accession 0001398733-26-000042.Report this figure175Total liabilities, Q1 FY2026, at 2026-03-31$175.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-13, accession 0001398733-26-000030.Report this figure189Total liabilities, Q2 FY2026, at 2026-06-30$188.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-11, accession 0001398733-26-000042.Report this figure
Long-term debt$m39.0Long-term debt, Q3 FY2023, at 2023-09-30$39.0m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2023-11-06, accession 0001628280-23-037100.Report this figure45.0Long-term debt, FY2023, at 2023-12-31$45.0m. XBRL concept us-gaap:LongTermDebt. 10-K filed 2024-03-05, accession 0001628280-24-009010.Report this figure45.0Long-term debt, Q1 FY2024, at 2024-03-31$45.0m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2024-05-07, accession 0001628280-24-021118.Report this figure45.0Long-term debt, Q2 FY2024, at 2024-06-30$45.0m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2024-08-06, accession 0001628280-24-035225.Report this figure45.0Long-term debt, Q3 FY2024, at 2024-09-30$45.0m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2024-11-04, accession 0001628280-24-045030.Report this figure45.0Long-term debt, FY2024, at 2024-12-31$45.0m. XBRL concept us-gaap:LongTermDebt. 10-K filed 2025-03-05, accession 0001628280-25-010506.Report this figure45.0Long-term debt, Q1 FY2025, at 2025-03-31$45.0m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2025-05-12, accession 0001628280-25-024664.Report this figure45.0Long-term debt, Q2 FY2025, at 2025-06-30$45.0m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2025-08-11, accession 0001398733-25-000013.Report this figure45.0Long-term debt, Q3 FY2025, at 2025-09-30$45.0m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2025-11-05, accession 0001398733-25-000028.Report this figure45.0Long-term debt, FY2025, at 2025-12-31$45.0m. XBRL concept us-gaap:LongTermDebt. 10-K filed 2026-03-04, accession 0001398733-26-000018.Report this figure45.0Long-term debt, Q1 FY2026, at 2026-03-31$45.0m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2026-05-13, accession 0001398733-26-000030.Report this figure55.0Long-term debt, Q2 FY2026, at 2026-06-30$55.0m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2026-08-11, accession 0001398733-26-000042.Report this figure
Current portion of debt$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported10.0Current portion of debt, FY2025, at 2025-12-31$10.0m. XBRL concept us-gaap:DebtCurrent. 10-Q filed 2026-08-11, accession 0001398733-26-000042.Report this figurenot reported0.0Current portion of debt, Q2 FY2026, at 2026-06-30$32.0k. XBRL concept us-gaap:DebtCurrent. 10-Q filed 2026-08-11, accession 0001398733-26-000042.Report this figure
Shareholders' equity$m(103)Shareholders' equity, Q3 FY2023, at 2023-09-30−$102.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-04, accession 0001628280-24-045030.Report this figure(106)Shareholders' equity, FY2023, at 2023-12-31−$106.5m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-04, accession 0001398733-26-000018.Report this figure(36.3)Shareholders' equity, Q1 FY2024, at 2024-03-31−$36.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-05, accession 0001398733-25-000028.Report this figure(35.5)Shareholders' equity, Q2 FY2024, at 2024-06-30−$35.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-05, accession 0001398733-25-000028.Report this figure(45.4)Shareholders' equity, Q3 FY2024, at 2024-09-30−$45.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-05, accession 0001398733-25-000028.Report this figure(60.2)Shareholders' equity, FY2024, at 2024-12-31−$60.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001398733-26-000042.Report this figure(60.9)Shareholders' equity, Q1 FY2025, at 2025-03-31−$60.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001398733-26-000042.Report this figure(72.6)Shareholders' equity, Q2 FY2025, at 2025-06-30−$72.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001398733-26-000042.Report this figure(4.1)Shareholders' equity, Q3 FY2025, at 2025-09-30−$4.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-05, accession 0001398733-25-000028.Report this figure(33.7)Shareholders' equity, FY2025, at 2025-12-31−$33.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001398733-26-000042.Report this figure(34.1)Shareholders' equity, Q1 FY2026, at 2026-03-31−$34.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001398733-26-000042.Report this figure(56.6)Shareholders' equity, Q2 FY2026, at 2026-06-30−$56.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001398733-26-000042.Report this figure

Cash flow

Operating cash flow−$9.4m, Q2 FY2026
Capital expenditure$212.0k, Q2 FY2026
Aquestive Therapeutics, Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(2.3)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$2.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-04, accession 0001628280-24-045030. Derived: 9-month figure less the 6-month figure.Report this figure(4.9)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$4.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-05, accession 0001628280-25-010506. Derived: 12-month figure less the 9-month figure.Report this figure(10.4)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$10.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-12, accession 0001628280-25-024664.Report this figure(7.0)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$7.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-11, accession 0001398733-25-000013. Derived: 6-month figure less the 3-month figure.Report this figure(11.9)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$11.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-05, accession 0001398733-25-000028. Derived: 9-month figure less the 6-month figure.Report this figure(6.5)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$6.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-04, accession 0001398733-26-000018. Derived: 12-month figure less the 9-month figure.Report this figure(23.4)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$23.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-13, accession 0001398733-26-000030.Report this figure(7.9)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$7.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-11, accession 0001398733-26-000042. Derived: 6-month figure less the 3-month figure.Report this figure(12.6)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$12.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-05, accession 0001398733-25-000028. Derived: 9-month figure less the 6-month figure.Report this figure(8.5)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$8.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-04, accession 0001398733-26-000018. Derived: 12-month figure less the 9-month figure.Report this figure(14.8)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$14.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-13, accession 0001398733-26-000030.Report this figure(9.4)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$9.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-11, accession 0001398733-26-000042. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.2Capital expenditure, Q3 FY2023, three months to 2023-09-30$151.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-04, accession 0001628280-24-045030. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2023, three months to 2023-12-31$16.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-05, accession 0001628280-25-010506. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2024, three months to 2024-03-31$29.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-12, accession 0001628280-25-024664.Report this figure0.0Capital expenditure, Q2 FY2024, three months to 2024-06-30$35.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-11, accession 0001398733-25-000013. Derived: 6-month figure less the 3-month figure.Report this figure0.1Capital expenditure, Q3 FY2024, three months to 2024-09-30$80.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-05, accession 0001398733-25-000028. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2024, three months to 2024-12-31$15.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-04, accession 0001398733-26-000018. Derived: 12-month figure less the 9-month figure.Report this figure0.1Capital expenditure, Q1 FY2025, three months to 2025-03-31$135.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-13, accession 0001398733-26-000030.Report this figure0.1Capital expenditure, Q2 FY2025, three months to 2025-06-30$107.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-11, accession 0001398733-26-000042. Derived: 6-month figure less the 3-month figure.Report this figure0.2Capital expenditure, Q3 FY2025, three months to 2025-09-30$235.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-05, accession 0001398733-25-000028. Derived: 9-month figure less the 6-month figure.Report this figure0.1Capital expenditure, Q4 FY2025, three months to 2025-12-31$85.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-04, accession 0001398733-26-000018. Derived: 12-month figure less the 9-month figure.Report this figure0.1Capital expenditure, Q1 FY2026, three months to 2026-03-31$52.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-13, accession 0001398733-26-000030.Report this figure0.2Capital expenditure, Q2 FY2026, three months to 2026-06-30$212.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-11, accession 0001398733-26-000042. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)124.99m, Q2 FY2026
Aquestive Therapeutics, Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares53.4Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3053,424,922 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-06, accession 0001628280-23-037100.Report this figure73.8Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3173,792,886 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-07, accession 0001628280-24-021118.Report this figure57.4Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3057,350,902 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-06, accession 0001628280-24-035225.Report this figure64.7Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3064,678,761 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-04, accession 0001628280-24-045030.Report this figure73.6Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3173,614,710 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-12, accession 0001628280-25-024664.Report this figure90.9Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3090,911,626 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-11, accession 0001398733-25-000013.Report this figure91.1Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3091,082,081 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-05, accession 0001398733-25-000028.Report this figure95.5Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3195,497,056 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-13, accession 0001398733-26-000030.Report this figure99.3Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3099,326,701 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-11, accession 0001398733-26-000042.Report this figure111Diluted shares (weighted), Q3 FY2025, three months to 2025-09-30110,584,371 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-05, accession 0001398733-25-000028.Report this figure123Diluted shares (weighted), Q1 FY2026, three months to 2026-03-31122,609,995 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-13, accession 0001398733-26-000030.Report this figure125Diluted shares (weighted), Q2 FY2026, three months to 2026-06-30124,994,165 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-11, accession 0001398733-26-000042.Report this figure

Shares outstanding: 125.51mShares outstanding, period not labelled, at 2026-08-07125,511,648 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-11, accession 0001398733-26-000042.Report this figure at Aug 7, 2026, from the cover of the 10-Q filed Aug 11, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:38 ET. Listed shows no prices and gives no investment advice.